SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001654954-21-000479
Filing Date
2021-01-14
Accepted
2021-01-14 17:01:57
Documents
2
Period of Report
2020-12-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT gtbp_def14c.htm DEF 14C 215229
2 IMAGE gtbp_def14c000.jpg GRAPHIC 4167
  Complete submission text file 0001654954-21-000479.txt   222446
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 000-08092 | Film No.: 21529518
SIC: 2834 Pharmaceutical Preparations